ZA979411B - The use of lithium compounds for combatting human papilloma virus infections. - Google Patents

The use of lithium compounds for combatting human papilloma virus infections.

Info

Publication number
ZA979411B
ZA979411B ZA9709411A ZA979411A ZA979411B ZA 979411 B ZA979411 B ZA 979411B ZA 9709411 A ZA9709411 A ZA 9709411A ZA 979411 A ZA979411 A ZA 979411A ZA 979411 B ZA979411 B ZA 979411B
Authority
ZA
South Africa
Prior art keywords
papilloma virus
human papilloma
virus infections
lithium compounds
combatting
Prior art date
Application number
ZA9709411A
Inventor
David Frederick Horrobin
Simon John Arthur Gilburt
Original Assignee
Scotia Holdings Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scotia Holdings Plc filed Critical Scotia Holdings Plc
Publication of ZA979411B publication Critical patent/ZA979411B/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA9709411A 1996-10-22 1997-10-21 The use of lithium compounds for combatting human papilloma virus infections. ZA979411B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9621990.2A GB9621990D0 (en) 1996-10-22 1996-10-22 Use

Publications (1)

Publication Number Publication Date
ZA979411B true ZA979411B (en) 1998-06-23

Family

ID=10801805

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9709411A ZA979411B (en) 1996-10-22 1997-10-21 The use of lithium compounds for combatting human papilloma virus infections.

Country Status (4)

Country Link
AU (1) AU4715397A (en)
GB (1) GB9621990D0 (en)
WO (1) WO1998017288A1 (en)
ZA (1) ZA979411B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001030355A1 (en) 1999-10-25 2001-05-03 Laboratoire Theramex Contraceptive medicine based on a progestational agent and an oestrogen and preparation method
SE513436C2 (en) 1999-01-21 2000-09-11 Astrid Agholme Use of a formulation containing formic acid for the manufacture of a medicament for the treatment of warts, caused by Papillomavirus
ES2164018B1 (en) * 2000-05-26 2003-06-16 Inst De Salud Carlos Iii USE OF A LITHIUM SALT IN THE PREPARATION OF A MEDICINAL PRODUCT FOR THE TREATMENT OF THE INFECTION CAUSED BY THE HUMAN SYNTHETIC RESPIRATORY VIRUS (VRDH)
US20040191207A1 (en) * 2003-03-31 2004-09-30 Lipari John M. Alpha-hydroxy acid ester drug delivery compositions and methods of use
US8048454B2 (en) 2004-03-09 2011-11-01 Michael Martin Methods and compositions related to regulation of cytokine production by glycogen synthase kinase 3 (GSK-3)
WO2016207366A1 (en) * 2015-06-26 2016-12-29 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods and pharmaceutical compositions for the treatment of viral infections

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3863678D1 (en) * 1987-04-27 1991-08-22 Efamol Holdings PHARMACEUTICAL PREPARATIONS CONTAINING LITHIUM SALTS.

Also Published As

Publication number Publication date
AU4715397A (en) 1998-05-15
WO1998017288A1 (en) 1998-04-30
GB9621990D0 (en) 1996-12-18

Similar Documents

Publication Publication Date Title
ZA977807B (en) New pharmaceutically active compounds.
ZA978639B (en) Use of 1-hydroxy-2-pyridones for the treatment of skin infections.
GB2341180A9 (en) Compounds on the basis of polyalkyl-1-oxa diazaspirodecane compounds
NO986086D0 (en) Process for the preparation of 17-esters of 9 <alpha>, 21-dihalo-pregnan-11
ZA979411B (en) The use of lithium compounds for combatting human papilloma virus infections.
AU2739497A (en) Use of vitamin d analogs for the treatment of arthritic disease
ZA977809B (en) New pharmaceutically active compounds.
GB9613360D0 (en) Disposable pouch
HUP0000483A3 (en) Use of aminoisothiazoles as microbicides
HUP9800032A3 (en) 3-aryluracil-derivatives, preparation and use thereof, herbicidal compositions containing these compounds and preparation of the latest
GB9425796D0 (en) The preparation of halogenated compounds
IL119744A (en) Use of 8,9-dehydroestrone for the preparation of antioxidant medicaments
GB9415313D0 (en) The preparation of organic compounds
HUP0004734A3 (en) Novel pharmaceutically active compounds, their preparation and use as ece-inhibitors
IT1283641B1 (en) PROCEDURE FOR THE PREPARATION OF CEPHALOSPORINE
ZA986324B (en) Composition for the treatment of immunodeficiency disease
SG81238A1 (en) Use of triphenylmethyl-1,2,3-triazoles
ZA956322B (en) The preparation of organic compounds
GB9601042D0 (en) Medical use
AU4581697A (en) Walker
AU9359898A (en) Use of moxonidine for the treatment of depression
GB9414973D0 (en) The preparation of organic compounds
IL118651A0 (en) Composition for the treatment of viral infections
ZA964250B (en) 2-amino-benzoxazinones for the treatment of viral infections.
ITMI970682A1 (en) PROCEDURE FOR THE PREPARATION OF (S) -N-TERBUTYL-1, 2, 3, 4- TETRAIDROISOCHINOLIN-3- CARBOXYAMIDE